Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Clinical trial NCT05644717 · RECRUITING

Trial details

NCT number: NCT05644717
Sponsor: Getz Pharma
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Fat Liver Fibrosis Glycemic Control Body Weight Changes Waist Circumference Tolerance

Start date: 2023-03-01
Primary completion: 2025-11-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.